On 18 October 2011, the European Court of Justice handed down a ruling in a case about German patents relating to isolated neural precursor cells, their production from embryonic stem cells, and their therapeutic use. The court’s judgment has received much discussion, a fair bit of it unfavourable. It raises important questions about bioethical principles, the regulation of biotechnology, and the role of the state in these controversial areas.
Follow the link below to read the rest of the article.
http://blog.talkingphilosophy.com/?p=3545
